Next Article in Journal
The Potential Role of Apigenin in Cancer Prevention and Treatment
Previous Article in Journal
Pumice as a Novel Natural Heterogeneous Catalyst for the Designation of 3,4-Dihydropyrimidine-2-(1H)-ones/thiones under Solvent-Free Conditions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 18
10.3390/molecules27186049
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neuroprotective Effects of a New Derivative of Chlojaponilactone B against Oxidative Damaged Induced by Hydrogen Peroxide in PC12 Cells

by
Shaoxia Ye
1,2,
Qiyin Wen
1,
Longping Zhu
1,
Chunguo Qian
1,
Depo Yang
1 and
Zhimin Zhao
1,*
1
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
2
The Second Affiliated Hospital of Xiamen Medical College, Xiamen 361021, China
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(18), 6049; https://doi.org/10.3390/molecules27186049
Submission received: 26 July 2022 / Revised: 31 August 2022 / Accepted: 7 September 2022 / Published: 16 September 2022
Browse Figures
Versions Notes

Abstract

:
A new sesquiterpenoid (1) was obtained by hydrogenating Chlojaponilactone B. The structure of 1 was elucidated according to a combination of NMR, HRESIMS, and NOE diffraction data. The treatment of H2O2 in a PC12 cell model was used to evaluate the antioxidant activity of 1. An MMT assay showed that 1 had no cytotoxicity to the PC12 cell and rescued cell viability from the oxidative damage caused by H2O2. The treatment of 1 stabilized the mitochondria membrane potential (MMP), which decreased the intracellular ROS level and reduced cell apoptosis in the oxidative stress model. The activities of antioxidant enzyme superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and the content of intracellular glutathione (GSH) were significantly enhanced after the treatment of 1. In addition, the results of qRT-PCR showed that 1 treatment minimized the cell injury by H2O2 via the up-regulation of the expression of nuclear factor erythroid 2 (Nrf2) and its downstream enzymes Heme oxygenase 1 (HO-1), glutamate cysteine ligase-modifier subunit (GCLm), and NAD(P)H quinone dehydrogenase 1 (Nqo1). Based on the antioxidant activity of 1, we speculated its potential as a therapeutic agent for some diseases induced by oxidative damage.

1. Introduction

Oxidative stress refers to a reaction in which the body generates a large number of reactive oxygen species after being stimulated by harmful stimuli, leading to an imbalance between the oxidation state and antioxidant state, resulting in pathological changes in tissues and cells [1]. Excessive amounts of highly active molecules are produced when the body is subjected to various stimuli, such as reactive oxygen species (ROS), causing the balance of oxidative and antioxidant states to be lost, which, in turn, results in tissue oxidative damage. Excessive free radicals produced by oxidative stress can directly or indirectly damage DNA, oxidize proteins, and reduce biological activity because of structural and functional defects [2]. Studies have shown that oxidative stress is closely related to neurological diseases, including Parkinson’s disease and Alzheimer’s disease [3,4], cardiovascular diseases and prostatic diseases [5], inflammation, and cancers [6]. The reduction in oxidative stress-induced damage to the body has become key in treating these clinical diseases. Treatment strategies based on the antioxidant amelioration of ROS appear to be able to delay the progression of these diseases.
Natural products are rich in resources and diverse in structure. Numerous studies have shown that antioxidants from natural plant sources have neuroprotective effects to reduce the probability of human diseases [7,8,9]. Demethylenetrahydroberberine was reported to protect dopaminergic neurons and alleviates the behavioral disorder in a mouse model of Parkinson’s disease through anti-apoptotic, anti-inflammatory and antioxidant effects [10]. Chen et al. found that GTS40, which is an active fraction of Gou Teng-San, helped prevent and treat oxidative stress-mediated neurodegenerative disorders [11]. Antioxidant peptides from protein hydrolysate of skipjack tuna milt showed protection for human umbilical vein endothelial cells under H2O2 stimuli [12]. A combination of natural antioxidants (Vitamin E, quercetin, and basil oil) is potential innovation against Alzheimer’s disorder [13]. Therefore, research on new natural compounds with neuroprotective activity are highly urgently and necessary. Finding lead compounds with novel structures and significant activity from natural products has become an effective way to develop new drugs. However, traditional compounds obtained by separation and extraction are limited in yield and cannot satisfy the needs of research and development. Chemical modifications or biotransformation of compounds have become important methods to improve pharmacological activity, reduce side effects, and increase drug stability.
The plants of genus Chloranthus are widely applied for Traditional Chinese Medicine to treat bruises, rheumatic arthralgia, pain, soreness, and furunculosis [14]. Many terpenoids have been reported, such as terpenoids, diterpenoids, sesquiterpenoid dimers, and sesquiterpene lactones, in phytochemical investigations of Chloranthus plants. Pharmacological research has shown that Chloranthus plant have anti-inflammatory, anti-tumor, antivirus, and antifungal activities [15]. Sesquiterpenoids are a diverse group of compounds with abundant pharmacological activity, which have attracted the attention of scholars in recent years. By modifying the structure of sesquiterpenoids with lower toxicity and higher activity, they can be used in new drugs, food and cosmetics. Our previous studies showed that chlojaponilactone B, a sesquiterpenoid isolated from the genus Chloranthus, has anti-inflammatory effects that rely on the C-6 acetyl group and the C-8–C-9 double bond [16,17]. In this study, we perhydrogenated chlojaponilactone B to explore its structure–activity relationship. The sesquiterpene compound chlojaponilactone B was modified to reduce the three double bonds in the structure and open the ring of cyclopropane to obtain a derivative, termed compound, 1. Surprisingly, we obtained a new compound (1) with strong anti-oxidant activities and inhibition of nitric oxide (NO) production (the value of IC50 is shown in Supplementary Materials). The aim of this study was to investigate the neuroprotective effect of compound 1 against oxidative damage to PC12 cells induced by H2O2.

2. Results and Discussion

2.1. Chemical Modification and Structure Elucidation

Our previous study speculated that the anti-inflammatory effects of Chlojaponilactone B depended on the C-6 acetyl group and the C-8–C-9 double bond [17]. To test this hypothesis, we perhydrogenated chlojaponilactone B into compound 1.
Compound 1 appeared as a white powder and has the molecular formula C17H26O4 according to the HRESIMS spectrum at m/z 317.1724 [M + Na] + (calculated as 317.1724), implying five indexes of hydrogen deficiency. 1H-NMR and 13C-NMR analysis of 1 (Table 1) revealed signals for protons representing five methyls (δH 0.80 (3H, s), 0.86 (3H, d, J = 6.76 Hz), 0.92 (3H, d, J = 7.00 Hz), 1.25 (3H, d, J = 7.36 Hz), and 2.02 (3H, s)). The 13C-NMR spectra, combined with DEPT 135 experiments, revealed seventeen signals, comprising one ester group (δC 178.4), one acetyl group (δC 169.9), five methyl groups (δC 10.4, 13.3, 16.2, 19.2, 21.8), two sp3 hybridized methylene groups, seven sp3 hybridized methine groups (two of which contained oxygens), and one sp3 hybridized quaternary carbon. Among the five unsaturated positions, one is occupied by ester groups, one is occupied by an acetyl group, and the remaining three unsaturated positions are presumed to be in a tricyclic structure in 1 (see Table 1).
The analysis and identification of the structure of compound 1 was achieved using various 2D NMR spectroscopic techniques. The heteronuclear multiple bond correlations (HMBCs) of H2-2/C-1, C-3 and C-10, H3-15/C-3, C-4 and C-5, H3-14/C-1, C-5, C-9, and C-10 indicated that C-1, C-3, C-4, C-5, and C-10 formed the five-membered ring, and the C-1, C-4, and C-10 positions were connected to one methyl group, respectively, which was supported by the 1H-1H correlated spectroscopy (COSY) correlations of H3-2/H-1/H2-3/H-4/H-5 and H-4/H3-15. The HMBCs of H3-14/C-5, C-9, and C-10, combined with the 1H-1H COSY correlations of H-5/H-6/H-7/H-8, suggested that the six-membered ring was formed by C-5, C-6, C-7, C-8, C-9, and C-10, for which a C-5–C-10 bridge connected it to the five-membered ring. The HMBC correlations of H3-13/C-7, C-11, and C-12, combined with the 1H-1H COSY correlations of H-7/H-11/H3-13, verified that C-7, C-8, C-11, and C-12 formed the furan lactone ring, for which a C-7–C-8 bridge connected it to the six-membered ring, and the C-11 position was connected to one methyl group. The HMBC correlations of H-6/COOCH3 indicated that the C-6 position was modified with an acetyl group. Therefore, the planar structure of 1 was identified as a 2,3-ring guaianese sesquiterpene.
We analyzed its nuclear Overhauser effect (NOE) spectrum and compared its configuration with the known compound, chlojaponilactone B (Figure 1), which determined the absolute configuration of 1. Compound 1 is the perhydrogenated and cyclopropyl ring-opened product of Chlojaponilactone B. After opening the cyclopropyl moiety, C-1 maintains the R configuration, and C-5, C-6, and C-10 keep their S, R, and S configurations, respectively. The NOE spectrum indicated that H-6 is related to H3-13/H3-14/H3-15; H3-14 is related to H3-15; and H-4 is related to H-5, which determined C-4 as being in the S configuration. The correlation between H-8 and H-7/H-11, the correlation between H-7 and H-11, and the coupling constant of H-7 and H-8 was 1.52, which suggested that H-7 and H-8 are on the same side, and H-6 and H3-13 in the binding spectrum are related; therefore, the absolute configurations of C-7, C-8, and C-11 were determined as R, R, and S, respectively. Thus, the structure of compound 1 was established as depicted in Figure 1, and was named Perhydrochlojaponilactone B.

2.2. Neuroprotective Effect of Compound 1 against PC12 Cell Injury Induced by H2O2

PC12 cells were cloned from rat adrenal pheochromocytoma and differentiated into sympathetic nerve cells using nerve growth factor (NGF) stimulation, which have been widely used in studies of neurological diseases [18]. PC12 cell treating with H2O2 is a common model to study oxidative damage, which will cause cell membrane and nuclear damage, the loss of mitochondrial membrane potential (MMP), and the decreased activities of antioxidant enzymes, containing glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and the cellular glutathione (GSH) content [19,20,21].
PC12 cells were exposed to different concentrations of compound 1 to determine its cytotoxicity, as assessed using an MTT-based colorimetric test. As shown in Figure 2A, cell viability approached 100% at the concentration of 40 μM, 20 μM, 10 μM, 5 μM, and 2.5 μM, suggesting that 1 had no cytotoxicity to PC12 cell. To choose a proper concentration of H2O2, cells were treated with varying concentrations for 24 h. With increasing H2O2 concentration, the cell viability decreased in a linear manner (53.94% at 750 μM) (Figure 2B). Therefore, we selected 750 μM H2O2 to induce oxidative damage in at least half of the viable cells. The H2O2-induced decrease in cell viability was ameliorated dramatically after treatment with 1 in a dose-dependent manner. Cell viability after treatment of 1 at 40 μM was approaching to that treated with Vitamin C (VC, 10 μM), which was dramatically enhanced compared to the group induced with H2O2 (p < 0.05). In particular, 1 displayed a strong anti-oxidative effect at a lower concentration (2.5 μM) (Figure 2C). These results confirmed the non-cytotoxicity and antioxidant activity of 1 on PC12 cells.

2.3. Effects of 1 on ROS Generation in H2O2-Induced PC12 Cells

Oxidative stress leads to neutrophil infiltration, and increased secretion of nucleic acids [22], ultimately caused various chronic diseases. ROS are derivatives of free radicals, and include hydrogen peroxide, singlet oxygen, and ozone. ROS in the body have certain functions, such as participating in immune and signal transduction processes. In the normal physiological state, the production and clearance of free radicals in the body maintain a dynamic balance. The production and clearance of ROS is an important marker of redox homeostasis. Under normal physiological conditions, cells eliminate the accumulated ROS by generating antioxidants [23]. When the body or immune cells (macrophages and neutrophils) are subjected to harmful stimuli, ROS clearance is reduced, causing oxidative damage and even cell death [24]. Thus, excess ROS exhibits destructive behavior. As shown in Figure 3, intracellular ROS showed a burst increase in H2O2-treated PC12 cells. However, compound 1 treatment decreased ROS levels in PC12 cells after 24 h. These findings suggested that compound 1 could effectively antagonize the ROS accumulation in PC12 cells induced by H2O2.

2.4. Effects of 1 on the Recovery of the Loss of MMP in H2O2-Induced PC12 Cells

Mitochondria are important in many biological processes, including ROS generation, apoptosis, the cell cycle, and cell growth. However, when the body is stimulated by endotoxins or alcohol, the antioxidant system is damaged, and ROS clearance is blocked. The accumulated ROS led to mitochondrial membrane damage and mitochondrial membrane potential (MMP) reduction [25]. In order to investigate H2O2-induced mitochondrial dysfunction in PC12 cells, JC-1 Kits were used for MMP detection. Moreover, apoptosis was detected quantitatively using flow cytometry. As shown in Figure 4, after exposure to H2O2, PC12 cells displayed a dramatic increase in cell apoptosis (p < 0.001). By contrast, 1 treatment dose-dependently decreased the number of apoptotic cells. These results suggested that 1 could restore the decrease in cellular MMP and attenuate oxidative stress-induced cell apoptosis, thus exerting a neuroprotective effect.

2.5. Effects of 1 on SOD and GSH-Px Activities, and GSH Levels in H2O2-Induced PC12 Cells

GSH-Px is an important peroxide decomposition enzyme that catalyzes GSH to generate glutathione disulfide and reduces toxic H2O2 to non-toxic hydroxyl compounds. The enzymes GSH-Px and SOD are important oxygen free radical scavengers in cells. GSH is a natural tripeptide composed of glutamate, cysteine, and glycine, comprising a sulfhydryl compound that contributes to the reductive catalysis of thiol and disulfide bonds, which plays an important role in maintaining redox homeostasis. The reduction in glutathione in the brain is associated with Parkinson’s disease and aging [26]. The antioxidant system comprising GSH, GSH-Px, and SOD maintains the body’s redox homeostasis under physiological conditions.
To further explore the effect of 1 on antioxidants in H2O2-stimulated PC12 cells, we used ELISA to detect SOD and GSH-Px activities and GSH levels. The SOD activity in the H2O2 stimulation group decreased significantly compared to that in the control group (p < 0.05), whereas the SOD activity was enhanced after treatment with 1 in a dose-dependent manner. The GSH-Px activity decreased significantly (p < 0.05) in the H2O2 stimulation group, while 1 treatment enhanced the activity of GSH-Px, with the highest level at 10 μM. The GSH content in the H2O2 group decreased compared to control group (p < 0.05). However, the GSH content increased dose-dependently after 1 treatment (Figure 5). These findings suggested that 1 could increase antioxidant levels, thereby exerting an antioxidant effect.

2.6. Effects of 1 on the mRNA Expression Levels of Antioxidant Proteins in PC12 Cells Induced with H2O2

Furthermore, to preliminarily explore the mechanism of the protective effects of 1 against damage by H2O2 in PC12 cells, qRT-PCR was performed to detect the expression levels of nuclear factor erythroid 2 (Nrf2), glutamate cysteine ligase-modifier subunit (GCLm), heme oxygenase 1 (HO-1), and NAD(P)H quinone dehydrogenase 1 (Nqo1). Nrf2 regulates detoxification and downstream antioxidant enzyme gene expression, including Nqo1, GCLm, and HO-1. Nrf2 also regulates SOD and GSH-Px activities and the GSH level [27,28,29,30]. As shown in Figure 6, exposure to H2O2 downregulated the transcription of Nrf2, GCLm, HO-1, and Nqo1, whereas compound 1 treatment dose-dependently increased the mRNA expression levels of these antioxidant proteins.

3. Materials and Methods

3.1. Reagents

Methyl thiazolyl tetrazolium (MTT), JC-1 Kit assay kit, 2′,7′-dichlorofluorescein diacetate (DCFH-DA) fluorescent dye were purchased from the Beyotime Institute of Biotechnology (Shanghai, China). The SOD, GSH-Px and GSH immunosorbents assay kits were purchased from Beijing Solarbio Technology (Beijing, China) Co., Ltd. All primers were purchased from Sangon Biotech (Shanghai, China) Co., Ltd. Other chemicals and solvents used in the present study were of analytical or biological grade.

3.2. Cell Culture

The Cell Bank of Shanghai Institute of Biochemistry and Cell Biology (Shanghai, China) provided the PC12 cells. The cells were cultured in Roswell Park Memorial Institute 1640 (RPMI 1640, Gibco, Grand Island, NY, USA) medium containing 100 U/mL penicillin (HyClone, Logan, UT, USA), 100 g/mL streptomycin (HyClone), 5% Horse Serum (Gibco), and 5% fetal bovine serum (FBS, Gibco), in a humid atmosphere containing 5% CO2 at 37 °C.

3.3. Assay of Cell Viability

A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to assess the ability of 1 to protect PC12 cells against injury induced by H2O2. PC12 cells were added to the wells of 96-well plates (5 × 104 cells/mL) and cultured for 24 h. Thereafter, the cells were treated with different concentrations (40, 20, 10, 5, and 2.5 μM) of 1 or VC (10 μM) with H2O2 (750 μM). Cells treated with H2O2 (750 μM) served as the model group, those treated with 0.5% DMSO served as the blank control. Then, MTT (20 µL of a 5 mg/mL solution in sterile phosphate-buffered saline (PBS)) was added to the wells and incubated for 4 h, after which the medium was aspirated off and discarded. Finally, each well received 100 µL of DMSO, followed by microplate reader (Molecular Devices, Sunnyvale, CA, USA) detection of the absorbance (A) at 490 nm.

3.4. ROS Measurement

Intracellular ROS contents were determined using a 2,7-dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay. PC12 cells were seeded in a 6-well plate at 1 × 106 cells/mL, cultured for 24 h, and then treated with H2O2 (750 μM) as the model group. The blank group was treated with 0.5% DMSO, and the treatment group comprised cells treated with 1 at different concentrations (20, 10, and 5 μM) combined with H2O2 (750 μM) (both for 24 h). Next, 10 μM DCFH-DA was added to the cells and incubated for 30 min. Flow cytometry (Beckman coulter, Indianapolis, IN, USA) was used to observe the fluorescence of intracellular ROS.

3.5. Mitochondrial Membrane Potential

A JC-1 Kit was used to assess changes to the mitochondrial membrane potential, a commonly used marker of early apoptosis. PC12 cells were added to the wells of a 12-well plate at 1 × 105 cells/mL and incubated for 24 h, after which they were treated with 1 at different concentrations (20, 10, and 5 μM) with H2O2 (750 μM) for another 24 h. Wells with no test compound that received only H2O2 (750 μM) served as controls; wells with neither any test compound nor H2O2 (750 μM) served as blank controls. We harvested the cells, and rinsed them using PBS, then subjected them to flow cytometry to analyze fluorescence.

3.6. Measurement of Intracellular Antioxidant Activity

The intracellular SOD and GSH-Px activities, and the level of GSH in PC12 cells were measured employing enzyme-linked immunosorbents assay (ELISA) kits (Solarbio, Beijing, China). Briefly, the cells were treated the same as in Section 3.5. After 24 h of stimulation, cell lysis was achieved by incubation on ice, the cell lysate was collected, and the proteins were obtained by centrifugation for 10 min at 12,000× g and 4 °C. A Pierce™ BCA Protein Assay Kit (Thermo Fisher, San Diego, CA, USA) was used to quantify the total proteins in the samples. The absorbance of GSH-Px, SOD, and GSH were detected at 412, 560, and 412 nm, respectively.

3.7. Analysis of Antioxidant Gene Expression by Quantitative Real-Time Reverse Transcription PCR (qRT-PCR)

PC12 cells were added to 6-well plates at 1 × 106 cells/mL and incubated for 24 h. Subsequently, the model group comprised cells exposed with H2O2 (750 μM), the blank group comprised cells treated with 0. 5% DMSO, and the treatment group comprised cells treated at different concentrations of 1 (2.5, 5, and 10 μM) combined with H2O2 (750 μM) (all groups were treated for 24 h). The Trizol reagent (Invitrogen, Grand Island, NY, USA) was used to extract total RNA from the PC12 cells, and a Nanodrop 2000 ultramicro spectrophotometer (Thermo Fisher Scientific, Sacramento, CA, USA) was used to determine the RNA concentration. A HiScript II Q RT SuperMix for qPCR (Vazyme, Nanjing, China) was used to reverse-transcribe the mRNA into first strand cDNA. Next, a Hieff™qPCR SYBR® Green Master Mix (Yisheng, Shanghai, China) in a LightCycler 96 Real-Time PCR System (Roche, Basle, Switzerland) was used to perform quantitative real-time PCR (qPCR) assays using the cDNA as the template. The qPCR reaction conditions comprised: preincubation at 95 °C for 5 min, then 40 cycles of denaturation at 95 °C for 10 s, annealing at 55 °C for 20 s, and elongation at 72 °C for 20 s. Table 2 shows the gene-specific oligonucleotide primers employed in qPCR. The reference gene comprised GAPDH (glyceraldehyde 3-phosphate dehydrogenase). All experiments were carried out three times.

3.8. Statistical Analysis

Values are presented as the means ± SD of triplicate experiments. were performed using One-way analysis variance was used to carry out the statistical analyses in SPSS 18.0 (IBM Corp., Armonk, New York, NY, USA). Statistically significant differences were accepted at a p-value less than 0.05.

4. Conclusions

In this study, the sesquiterpene compound chlojaponilactone B was modified to reduce the three double bonds in the structure and open the ring of cyclopropane to obtain a new derivative, named compound 1. Extensive activity screening found that 1 has strong anti-oxidant activities. Compound 1 could significantly reverse the oxidative damage caused by H2O2 in the oxidative stress model of PC12 cells. Further study showed that ROS production in oxidatively damaged cells was inhibited significantly by the application of 1. Flow cytometry showed that after H2O2 (750 μM) stimuli, ROS levels in PC12 cells increased significantly; however, after 1 intervention, ROS levels decreased clearly. Compound 1 increased the cellular MMP, and attenuate oxidative stress induced cell apoptosis. Moreover, compound 1 enhanced SOD and GSH-Px activities and GSH levels markedly; it also dose-dependently increased the mRNA expression levels of Nrf2, GCLm, HO-1, and Nqo1, proving that 1 has a strong antioxidant effect. In conclusion, Compound 1 is a potentially promising therapeutic agent to treat oxidative damage-induced diseases in future research.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27186049/s1, Figure S1: 1H-NMR spectrum of compound 1 (CDCl3, 400 MHz), Figure S2: 13C-NMR spectrum of compound 1, Figure S3: DEPT 135°NMR spectrum of compound 1, Figure S4: 1H-1H COSY spectrum of compound 1, Figure S5: HSQC spectrum of compound 1, Figure S6: HMBC spectrum of compound 1, Figure S7: NOESY spectrum of compound 1, Figure S8: HRESIMS of compound 1, S9: The method of NO production, Figure S9: Dose-effect curve of compound 1 on LPS-induced NO inhibition.

Author Contributions

Conceptualization, S.Y. and Z.Z.; methodology, L.Z.; software, C.Q.; validation, Q.W.; investigation, S.Y. and Q.W.; resources, Z.Z.; writing—original draft preparation, S.Y.; writing—review and editing, Z.Z. and Q.W.; project administration, Z.Z. and D.Y.; funding acquisition, Z.Z and D.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Natural Science Foundation of China (NO. 82073735), Guangzhou Science and Technology Project (NO. 201904010203), Education and Research Project for Young and Middle-Aged Teachers of Fujian (No. JAT210488).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in article and Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not available.

References

  1. Lushchak, V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224, 164–175. [Google Scholar] [CrossRef] [PubMed]
  2. Jakubczyk, K.; Dec, K.; Kałduńska, J.; Kawczuga, D.; Kochman, J.; Janda, K. Reactive oxygen species—sources, functions, oxidative damage. Pol. Merkur. Lekarski 2020, 48, 124–127. [Google Scholar]
  3. Angelova, P.R.; Abramov, A.Y. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. Febs Lett. 2018, 592, 692–702. [Google Scholar] [CrossRef]
  4. Singh, A.; Kukreti, R.; Saso, L.; Kukreti, S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules 2019, 24, 20. [Google Scholar] [CrossRef] [PubMed]
  5. Zhao, M.J.; Yuan, S.; Zi, H.; Gu, J.M.; Fang, C.; Zeng, X.T. Oxidative Stress Links Aging-Associated Cardiovascular Diseases and Prostatic Diseases. Oxid. Med. Cell. Longev. 2021, 2021, 5896136. [Google Scholar] [CrossRef]
  6. Gorrini, C.; Harris, I.S.; Mak, T.W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 2013, 12, 931–947. [Google Scholar] [CrossRef]
  7. Chen, X.; Drew, J.; Berney, W.; Lei, W. Neuroprotective Natural Products for Alzheimer’s Disease. Cells 2021, 10, 1309. [Google Scholar] [CrossRef]
  8. Chen, B.; Zhao, J.J.; Zhang, R.; Zhang, L.L.; Zhang, Q.; Yang, H.; An, J. Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis. Nutr. Neurosci. 2022, 25, 1078–1099. [Google Scholar] [CrossRef]
  9. Kryl’skii, E.D.; Chupandina, E.E.; Popova, T.N.; Shikhaliev, K.S.; Mittova, V.O.; Popov, S.S.; Verevkin, A.N.; Filin, A.A. Neuroprotective effect of 6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline mediated via regulation of antioxidant system and inhibition of inflammation and apoptosis in a rat model of cerebral ischemia/reperfusion. Biochimie 2021, 186, 130–146. [Google Scholar] [CrossRef]
  10. Wen, J.; Zhang, Y.Q.; Liu, D.Q.; Yao, X.T.; Jiang, H.; Zhang, Y.B. Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson’s disease. Chin. J. Nat. Med. 2022, 20, 111–119. [Google Scholar] [CrossRef]
  11. Chen, L.; Wei, M.L.; Zhao, J.J.; Hong, H.; Qu, W.; Feng, F.; Liu, W.Y. GTS40, an active fraction of Gou Teng-San (GTS), protects PC12 from H2O2-induced cell injury through antioxidative properties. Chin. J. Nat. Med. 2017, 15, 495–504. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, Y.M.; Li, X.Y.; Wang, J.; He, Y.; Chi, C.F.; Wang, B. Antioxidant peptides from protein hydrolysate of skipjack tuna milt: Purification, identification, and cytoprotection on H2O2 damaged human umbilical vein endothelial cells. Process Biochem. 2022, 113, 258–269. [Google Scholar] [CrossRef]
  13. Karthika, C.; Appu, A.P.; Akter, R.; Rahman, M.H.; Tagde, P.; Ashraf, G.M.; Abdel-Daim, M.M.; ul Hassan, S.S.; Abid, A.; Bungau, S. Potential innovation against Alzheimer’s disorder: A tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery. Environ. Sci. Pollut. Res. 2022, 29, 10950–10965. [Google Scholar] [CrossRef] [PubMed]
  14. Flora of China Editorial Committee. Flora of China; Science Press: Beijing, China, 1982; Volume 20, p. 85. [Google Scholar]
  15. Chen, F.Y.; Bian, Y.T.; Huang, W.M.; Chen, Z.C.; Shuang, P.C.; Feng, Z.G.; Luo, Y.M. Research progress on chemical constituents from Chloranthus plants and their biological activities. China J. Chin. Mater. Med. 2021, 46, 3789–3796. [Google Scholar] [CrossRef]
  16. Zhao, J.J.; Guo, Y.Q.; Yang, D.P.; Xue, X.; Liu, Q.; Zhu, L.P.; Yin, S.; Zhao, Z.M. Chlojaponilactone B from Chloranthus japonicus: Suppression of Inflammatory Responses via Inhibition of the NF-κB Signaling Pathway. J. Nat. Prod. 2016, 79, 2257–2263. [Google Scholar] [CrossRef]
  17. Ye, S.X.; Zheng, Q.Y.; Zhou, Y.; Bai, B.; Yang, D.P.; Zhao, Z.M. Chlojaponilactone B Attenuates Lipopolysaccharide-Induced Inflammatory Responses by Suppressing TLR4-Mediated ROS Generation and NF-κB Signaling Pathway. Molecules 2019, 24, 3731. [Google Scholar] [CrossRef]
  18. Zhang, M.; Wang, D.; Li, B. Neuroprotection of two C21 steroidal glycosides from Cynanchum auriculatum against H2O2-induced damage on PC12 cells. Nat. Prod. Res. 2021, 35, 1752–1755. [Google Scholar] [CrossRef]
  19. Li, K.; Wang, L.Y.; Hu, Y.; Zhu, Z.Y. Structural characterization and protective effect on PC12 cells against H2O2-induced oxidative damage of a polysaccharide extracted from mycelia of Lactarius deliciosus Gray. Int. J. Biol. Macromol. 2022, 209, 1815–1825. [Google Scholar] [CrossRef]
  20. Qi, S.D.; Zhang, X.J.; Fu, Z.Z.; Pi, A.R.; Shi, F.Y.; Fan, Y.A.; Zhang, J.H.; Xiao, T.T.; Shang, D.; Lin, M.; et al. (+/−)-5-bromo-2-(5-fluoro-1-hydroxyamyl) Benzoate Protects Against Oxidative Stress Injury in PC12 Cells Exposed to H2O2 Through Activation of Nrf2 Pathway. Front. Pharmacol. 2022, 13, 13. [Google Scholar] [CrossRef]
  21. Chen, J.; Chen, Y.X.; Zheng, Y.F.; Zhao, J.W.; Yu, H.L.; Zhu, J.J. Relationship between Neuroprotective Effects and Structure of Procyanidins. Molecules 2022, 27, 18. [Google Scholar] [CrossRef]
  22. Gallo, G.; Sprovieri, P.; Martino, G. 4-hydroxynonenal and oxidative stress in several organelles and its damaging effects on cell functions. J. Physiol. Pharmacol. 2020, 71, 15–33. [Google Scholar] [CrossRef]
  23. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef] [PubMed]
  24. Herb, M.; Schramm, M. Functions of ROS in Macrophages and Antimicrobial Immunity. Antioxidants 2021, 10, 313. [Google Scholar] [CrossRef]
  25. Peoples, J.N.; Saraf, A.; Ghazal, N.; Pham, T.T.; Kwong, J.Q. Mitochondrial dysfunction and oxidative stress in heart disease. Exp. Mol. Med. 2019, 51, 1–13. [Google Scholar] [CrossRef] [PubMed]
  26. Zeevalk, G.D.; Razmpour, R.; Bernard, L. Glutathione and Parkinson’s disease: Is this the elephant in the room? Biomed. Pharmacother. 2008, 62, 236–249. [Google Scholar] [CrossRef] [PubMed]
  27. Chen, Q.M. Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury. Free Radic. Biol. Med. 2022, 179, 133–143. [Google Scholar] [CrossRef] [PubMed]
  28. Clementi, M.E.; Lazzarino, G.; Sampaolese, B.; Brancato, A.; Tringali, G. DHA protects PC12 cells against oxidative stress and apoptotic signals through the activation of the NFE2L2/HO-1 axis. Int. J. Mol. Med. 2019, 43, 2523–2531. [Google Scholar] [CrossRef]
  29. Kasai, S.; Shimizu, S.; Tatara, Y.; Mimura, J.; Itoh, K. Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology. Biomolecules 2020, 10, 320. [Google Scholar] [CrossRef]
  30. Peng, S.; Hou, Y.; Yao, J.; Fang, J. Activation of Nrf2 by costunolide provides neuroprotective effect in PC12 cells. Food Funct. 2019, 10, 4143–4152. [Google Scholar] [CrossRef]
Molecules 27 06049 g001 550
Figure 1. The structures of (A) Compound 1 (Perhydrochlojaponilactone B); (B) Chlojaponilactone B.
Figure 1. The structures of (A) Compound 1 (Perhydrochlojaponilactone B); (B) Chlojaponilactone B.
Molecules 27 06049 g001
Molecules 27 06049 g002 550
Figure 2. Compound 1 had no cytotoxicity to PC12 cells and ameliorated oxidative damage induced by H2O2 treatment. (A) Cell viability after exposed to various concentrations of 1 (2.5, 5, 10, 20 and 40 μM) or VC for 24 h; (B) cells were treated with different concentrations of H2O2 for 24 h; (C) cell viability after treatment of 1 or VC in H2O2−induced oxidative stress cell model. Cells treated with VC as the positive control. # p < 0.05 vs. control cells. * p < 0.05 vs. H2O2-treated cells.
Figure 2. Compound 1 had no cytotoxicity to PC12 cells and ameliorated oxidative damage induced by H2O2 treatment. (A) Cell viability after exposed to various concentrations of 1 (2.5, 5, 10, 20 and 40 μM) or VC for 24 h; (B) cells were treated with different concentrations of H2O2 for 24 h; (C) cell viability after treatment of 1 or VC in H2O2−induced oxidative stress cell model. Cells treated with VC as the positive control. # p < 0.05 vs. control cells. * p < 0.05 vs. H2O2-treated cells.
Molecules 27 06049 g002
Molecules 27 06049 g003 550
Figure 3. Effect of 1 on ROS production in PC12 cells induced by H2O2, as determined using flow cytometry. Cells were treated with various concentrations of 1 (5, 10, 20 μM) combined with H2O2 (750 μM); control group is treated with 0.5% dimethyl sulfoxide (DMSO) for 24 h.
Figure 3. Effect of 1 on ROS production in PC12 cells induced by H2O2, as determined using flow cytometry. Cells were treated with various concentrations of 1 (5, 10, 20 μM) combined with H2O2 (750 μM); control group is treated with 0.5% dimethyl sulfoxide (DMSO) for 24 h.
Molecules 27 06049 g003
Molecules 27 06049 g004 550
Figure 4. Compound 1 restored the loss of mitochondria membrane potential (MMP) in H2O2 treated PC12 cells. The MMP was assessed using flow cytometry. PC12 cells were treated with (A) control; (B) H2O2 (750 μM), and varied concentrations of compound 1 (C) (5 μM); (D) (10 μM); (E) (20 μM) combined with H2O2 (750 μM) for 24 h; (F) Apoptosis cell rate of different groups ### p < 0.005 vs. control cells. ** p < 0.01, *** p < 0.005 vs. H2O2-treated cells.
Figure 4. Compound 1 restored the loss of mitochondria membrane potential (MMP) in H2O2 treated PC12 cells. The MMP was assessed using flow cytometry. PC12 cells were treated with (A) control; (B) H2O2 (750 μM), and varied concentrations of compound 1 (C) (5 μM); (D) (10 μM); (E) (20 μM) combined with H2O2 (750 μM) for 24 h; (F) Apoptosis cell rate of different groups ### p < 0.005 vs. control cells. ** p < 0.01, *** p < 0.005 vs. H2O2-treated cells.
Molecules 27 06049 g004
Molecules 27 06049 g005 550
Figure 5. SOD, GSH−Px activities and GSH levels in PC12 cells induced with H2O2. Cells were pretreated with different concentrations of 1 (5, 10, or 20 μM) and H2O2 (750 μM) for 24 h. (A) The SOD; (B) GSH−Px activities; (C) the GSH level # p < 0.05 vs. control cells. * p < 0.05 vs. H2O2-treated cells.
Figure 5. SOD, GSH−Px activities and GSH levels in PC12 cells induced with H2O2. Cells were pretreated with different concentrations of 1 (5, 10, or 20 μM) and H2O2 (750 μM) for 24 h. (A) The SOD; (B) GSH−Px activities; (C) the GSH level # p < 0.05 vs. control cells. * p < 0.05 vs. H2O2-treated cells.
Molecules 27 06049 g005
Molecules 27 06049 g006 550
Figure 6. Effects of 1 on the mRNA expression levels of (A) Nrf2; (B) HO-1; (C) GCLm; (D) Nqo1. PC12 cells were incubated with compound 1 at 2.5, 5, or 10 μM, combined with H2O2 (750 μM), for 24 h before assessment using qRT-PCR. GAPDH was used as the internal control. Values are representative of three independent experiments. # p < 0.05, ## p < 0.01, ### p < 0.005 vs. control cells. * p < 0.05, ** p < 0.01 vs. H2O2-induced cells.
Figure 6. Effects of 1 on the mRNA expression levels of (A) Nrf2; (B) HO-1; (C) GCLm; (D) Nqo1. PC12 cells were incubated with compound 1 at 2.5, 5, or 10 μM, combined with H2O2 (750 μM), for 24 h before assessment using qRT-PCR. GAPDH was used as the internal control. Values are representative of three independent experiments. # p < 0.05, ## p < 0.01, ### p < 0.005 vs. control cells. * p < 0.05, ** p < 0.01 vs. H2O2-induced cells.
Molecules 27 06049 g006
Table
Table 1. 1H-NMR (400 MHz) and 13C-NMR (100 MHz) of 1 (CDCl3, δ in ppm).
Table 1. 1H-NMR (400 MHz) and 13C-NMR (100 MHz) of 1 (CDCl3, δ in ppm).
Position δ CδH, multi. (J in Hz)
147.01.48, m
213.30.86, d (6.76)
341.30.99, m
2.16, m
430.42.14, m
554.31.81, dd (12.08, 8.64)
670.35.10, dd (12.08, 8.76)
748.12.62, ddd (12.32, 5.00, 1.00)
880.34.65, td (4.56, 1.52)
940.71.30, m
2.21, m
1043.8
1140.92.83, m
12178.4
1310.41.25, d (7.36)
1416.20.80, s
1519.20.92, d (7.00)
COOCH3169.9
COOCH321.82.02, s
Table
Table 2. Primer sequence.
Table 2. Primer sequence.
Gene SymbolForward Primer (5’-3’)Reverse Primer (5’-3’)
GADPHGGTGAAGGTCGGTGTGAACGCTCGCTCCTGGAAGATGGTG
GCLmCTTCGCCTCCGATTGAAGATGAAAGGCAGTCAAATCTGGTGG
HO-1AGATGGCGTCACTTCGTCAGGCTGATCTGGGGTTTCCCTC
Nrf2TTGGCAGAGACATTCCCATGCTGCCACCGTCACTGGG
Nqo1TGAAGAAGAGAGGATGGGAGGGATGACTCGGAAGGATACTGAAAG
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ye, S.; Wen, Q.; Zhu, L.; Qian, C.; Yang, D.; Zhao, Z. Neuroprotective Effects of a New Derivative of Chlojaponilactone B against Oxidative Damaged Induced by Hydrogen Peroxide in PC12 Cells. Molecules 2022, 27, 6049. https://doi.org/10.3390/molecules27186049

AMA Style

Ye S, Wen Q, Zhu L, Qian C, Yang D, Zhao Z. Neuroprotective Effects of a New Derivative of Chlojaponilactone B against Oxidative Damaged Induced by Hydrogen Peroxide in PC12 Cells. Molecules. 2022; 27(18):6049. https://doi.org/10.3390/molecules27186049

Chicago/Turabian Style

Ye, Shaoxia, Qiyin Wen, Longping Zhu, Chunguo Qian, Depo Yang, and Zhimin Zhao. 2022. "Neuroprotective Effects of a New Derivative of Chlojaponilactone B against Oxidative Damaged Induced by Hydrogen Peroxide in PC12 Cells" Molecules 27, no. 18: 6049. https://doi.org/10.3390/molecules27186049

Article Metrics

Back to TopTop